StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report released on Thursday. The brokerage issued a hold rating on the software maker’s stock.
Veradigm Stock Performance
MDRX stock opened at $9.51 on Thursday. Veradigm has a 1-year low of $5.01 and a 1-year high of $11.80. The company’s 50 day moving average is $9.98 and its 200 day moving average is $9.73.
Institutional Trading of Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new stake in shares of Veradigm Inc. (NASDAQ:MDRX – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- What is the Hang Seng index?
- Jabil’s Winning Streak Begins: Market Bottom Set, Future in Focus
- What Does a Stock Split Mean?
- High-Flying HEICO Eyes New Heights in 2025
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Beyond Reality: Investing in AR/VR Tech for Future Gains
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
